It is a pharma public limited company based in New Delhi, Delhi, India, established in 1985.
1985 | New Delhi, Delhi, India | ActiveSupriya Pharmaceuticals Limited, a active public limited company, was established on 24 July 1985 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U01100RJ1985PLC003363. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.64 Cr.
It upholds a compliant status. Its leadership includes Manish Gupta (Nominee Director), Ramesh Dugar (Nominee Director), Yogesh Kumar (Nominee Director). Past directors included Hitesh Chopra, Chandrakure Parmeshwaram Madhu Kumar, Gagnish Arora. It holds ₹3.00 Cr open charges and ₹7.94 Cr settled loans. Its latest AGM occurred on 04 June 2025, with the balance sheet filed on 31 March 2025. It is based at 810, Arunachal Building, 19, Barkhamba Road, Connaught Place, New Delhi, Delhi, 110001.
U01100DL1985PLC445217
445217
24 July 1985
₹10.00 Cr
₹9.64 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Supriya Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Gupta | Nominee Director | 06 Feb 2024 | Current |
| Ramesh Dugar | Nominee Director | 08 Feb 2012 | Current |
| Yogesh Kumar | Nominee Director | 16 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Jun 2009 | Past |
| Pramod Abcsdd | Director | 08 Feb 2012 | Past |
| Pramod Abcsdd | Director | 01 Dec 2007 | Past |
| Pramod Abcsdd | Director | 06 Feb 2024 | Past |
| Pramod Abcsdd | Director | 08 Feb 2012 | Past |
| Pramod Abcsdd | Managing Director | 08 Feb 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Supriya Pharmaceuticals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2019, Supriya Pharmaceuticals had a promoter holding of 35.36% and a public holding of 64.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,000,000.00
₹79,375,600.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2005 | United Bank Of India | ₹3.00 Cr | Satisfied |
| 21 Jan 1998 | Canara Bank | ₹0.30 M | Satisfied |
| 20 Aug 1992 | Canara Bank | ₹3.00 Cr | Satisfied |
| 31 Jan 1992 | Canara Bank | ₹3.00 M | Satisfied |
| 16 Aug 1991 | Canara Bank | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Supriya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Supriya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 22 Aug 2005 via Charge ID 90069297 with United Bank Of India was fully satisfied on 23 Sep 2025. was completed.
The activity Supriya Pharmaceuticals Limited last Annual general meeting of members was held on 04 Jun 2025 as per latest MCA records. was completed.
The activity Supriya Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Manish Gupta was appointed as a Nominee Director was appointed as a Nominee Director on 06 Feb 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
The activity Yogesh Kumar was appointed as a Nominee Director was appointed as a Nominee Director on 16 May 2017 & has been associated with this company since 8 years 8 months . was completed.
Ramesh Dugar was appointed as a Nominee Director was appointed as a Nominee Director on 08 Feb 2012 & has been associated with this company since 13 years 11 months . was recorded as a recent event.
The CIN of Supriya Pharmaceuticals Limited is U01100DL1985PLC445217.
Supriya Pharmaceuticals Limited is headquartered at 810, Arunachal Building, 19, Barkhamba Road, Connaught Place, New Delhi, Delhi, 110001.
Supriya Pharmaceuticals Limited was incorporated on 24 July 1985.
The current directors of Supriya Pharmaceuticals Limited are
The primary industry of Supriya Pharmaceuticals Limited is Manufacturing.
Supriya Pharmaceuticals Limited is unlisted.
The authorized capital of Supriya Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹9.64 Cr.
The compliance status of Supriya Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX